{{multiple issues|
{{context|date=April 2014}}
{{unreferenced|date=June 2009}}
}}
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 443763785
| IUPAC_name = isopentyl 2-[2-(diethylamino)ethylamino]-2-phenylacetate
| image = Camylofin.png

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|camylofin}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 54-30-8
| ATC_prefix = A03
| ATC_suffix = AA03
| PubChem = 5902
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 253592
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 340B6Q764V
|  ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 5691
|  smiles = O=C(OCCC(C)C)C(NCCN(CC)CC)c1ccccc1
|  StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C19H32N2O2/c1-5-21(6-2)14-13-20-18(17-10-8-7-9-11-17)19(22)23-15-12-16(3)4/h7-11,16,18,20H,5-6,12-15H2,1-4H3
|  StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = RYOOHIUJEJZCFT-UHFFFAOYSA-N

<!--Chemical data-->
| C=19 | H=32 | N=2 | O=2 
| molecular_weight = 320.47 g/mol
}}

'''Camylofin''' is an [[antimuscarinic]].

Camylofin is a [[smooth muscle]] relaxant with both [[anticholinergic]] action as well as direct [[smooth muscle]] action. Anticholinergic action is produced by inhibiting the binding of [[acetylcholine]] to [[muscarinic receptors]], but the action is less pronounced. Direct smooth muscle relaxation is achieved by inhibiting [[phosphodiesterase]] type IV, which leads to increased [[cyclic AMP]] and eventually reduced [[cytosolic]] calcium. Thus camylofin has a comprehensive action to relieve smooth muscle [[spasm]]. It is used to treat stomach ache in infants and children. Usually it is given in combination with [[paracetamol]] to treat stomach ache, as well as [[pyrexia]].

==References==
{{Reflist|2}}


{{Drugs for functional gastrointestinal disorders}}
{{Muscarinic acetylcholine receptor modulators}}

[[Category:Amines]]
[[Category:Carboxylate esters]]
[[Category:Muscarinic antagonists]]


{{gastrointestinal-drug-stub}}